Nyxoah S.A.

NASDAQ:NYXH

Medical - Instruments & Supplies

Healthcare
$0.86 +1.25%

+$0.02 today

Market cap
$87.89M
Beta
0.89
P/E (TTM)
-0.7
EPS (TTM)
-$1.99
52W Low $1.26High $8.59

Volume 0.17M

Average 0.22M

NYXH Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Nyxoah S.A.NASDAQ: NYXH

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares growth accelerates

Q1 FY2026 weighted avg shares of 43.21M shares rose 15.4% year over year, ahead of the +13.3% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 7.7% from the prior quarter. Over 3 fiscal years it compounded at +13.9% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +15.4% holds above the trailing-twelve-month pace of +13.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
43.21M+7.7% QoQ
Last fiscal yearDec 2025
38.11M+16.4% YoY
LTMMar 2026
39.55M+13.3% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+15.4%——
1 year+16.4%——
3-year CAGR+13.9%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
38.11M EUR
Year-over-year change
+16.4%
4-year CAGR
+12.5%

Weighted Avg Shares vs competitors

How NYXH compares with its peers on the latest reported figures

  • NYXH's LTM Mar 2026 weighted avg shares of 39.55M shares is the 8th highest of the 10 companies compared; the peer median is 54.95M shares.
  • Its year-over-year change of +13.3% is the 6th highest of 10, against a peer median of +15.1%.
  • Over three fiscal years its annual growth of +13.9% compares with a peer median of +10.4%.
NYXH Competitors Peer median
Weighted Avg Shares for NYXH and competitors
Company Period LTM YoY 3-year CAGR
IVVDInvivyd, Inc.LTM Mar 2026193.02M +61.8%+16.7%
OABIOmniAb, Inc.LTM Mar 2026119.25M +15.1%+10.0%
OSUROraSure Technologies, Inc.LTM Mar 202672.2M -3.1%+0.4%
STIMNeuronetics, Inc.LTM Mar 202667.96M +71.5%+34.8%
CATXPerspective Therapeutics, Inc.LTM Mar 202654.95M -21.6%+10.4%
KRMDKORU Medical Systems, Inc.LTM Mar 202646.25M +0.8%+0.9%
TARAProtara Therapeutics, Inc.LTM Mar 202643.36M +56.7%+56.1%
NYXHNyxoah S.A.LTM Mar 202639.55M +13.3%+13.9%
PREPrenetics Global LimitedLTM Mar 202615.04M +18.8%+40.5%
UTMDUtah Medical Products, Inc.LTM Mar 20263.28M -4.9%-3.1%
Peer median (excluding NYXH) 54.95M+15.1%+10.4%

Competitors are the stored peer set for NYXH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue852K3.08M4.35M4.52M10.02M
Cost of Revenue303K1.15M1.66M1.55M3.69M
Gross Profit549K1.93M2.69M2.97M6.33M
Gross Margin64.4%62.7%61.9%65.7%63.1%
Research & Development5.95M15.86M27.66M34.33M42.82M
Selling, General & Admin11.11M18.86M20.65M28.46M46.44M
Operating Expenses26.79M34.43M47.79M61.78M89.27M
Depreciation & Amortization1.66M1.93M2.36M764K4.48M
EBITDA(22.59M)(27.89M)(42.08M)(53.77M)(82.9M)
EBITDA Margin-2651.5%-904.2%-967.8%-1189.2%-827.4%
Operating Income(26.24M)(32.5M)(45.1M)(58.81M)(82.94M)
Operating Margin-3080.0%-1053.8%-1037.3%-1300.8%-827.8%
Interest Income1K372K2.57M2.5M1.83M
Interest Expense386K237K1.21M1.9M1.69M
Other Income / Expenses1.6M2.44M445K2.38M(6.13M)
Income Before Tax(24.64M)(30.06M)(44.66M)(56.43M)(89.08M)
Pre-Tax Margin-2891.9%-974.6%-1027.1%-1248.2%-889.0%
Income Tax Expense2.98M1.17M(1.45M)2.8M1.01M
Net Income(27.62M)(31.23M)(43.21M)(59.24M)(90.09M)
Net Margin-3241.7%-1012.5%-993.8%-1310.2%-899.1%
EPS (Basic)(1.16)(1.21)(1.55)(1.81)(2.37)
EPS (Diluted)(1.16)(1.21)(1.55)(1.81)(2.37)
Weighted Avg Shares23.79M25.82M27.97M32.74M38.11M
Weighted Avg Shares (Diluted)23.79M25.82M27.97M32.74M38.11M

Nyxoah S.A.

NASDAQ:NYXH

Intrinsic Alpha fair value

Locked

Current Price

$0.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.